CIK 0001642380 · Non-accelerated filer<br>Smaller reporting company
Insight Molecular Diagnostics Inc.
Sign in to watch- Ticker
- IMDX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- operating
- EIN
- 271041563
- Phone
- 949-409-7600
- Business address
- 2 INTERNATIONAL PLAZA DR., SUITE 510, NASHVILLE, TN, 37217
- Former names
- OncoCyte Corp, Oncocyte Corp
- 4 Grant or award Director acquired 1,705,000 shares (grant or award)
- 4 Grant or award Director acquired 423,252 shares (grant or award)
- 4 Other disposition 10% owner disposed of 3,890,111 shares (other)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 250,000 shares at $0.35 ($87,875)
- 4 Open-market buy Director bought 75,000 shares at $0.33 ($24,728)
- 4 Open-market buy Director bought 25,000 shares at $0.29 ($7,125)
- 4 Grant or award Former CSO acquired 213,797 shares (grant or award)
- 4 Returned to the company Former CSO. returned 150,000 shares (to the company)
- 4 Returned to the company Former President and COO returned 175,000 shares (to the company)
- 4 Option exercise Former CEO acquired 250,000 shares (option exercise)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 20,000 shares at $0.87 ($17,400)
- 4 Open-market buy Director bought 15,000 shares at $0.90 ($13,500)
Page 4 of 13 · 257 filings